All Stories

  1. Raf-kinase inhibitor protein (RKIP): A therapeutic target in colon cancer

    Article • Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, October 2025, Elsevier

    Dr Seema Kumari

  2. Role of Yin Yang 1 (YY1) on microenvironment, signaling pathways, and epigenetics in lung cancer

    Article • Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, September 2025, Elsevier

    Seema Kumari , Dr Seema Kumari

  3. Adiponectin: its role in diabetic and pancreatic cancer

    Article • Molecular Aspects of Medicine, June 2025, Elsevier

    Seema Kumari , Dr Seema Kumari

  4. DIFERULOYLMETHANE IDENTIFIED AGAINST CYSTEINE PROTEASES AND TMPRSS2 USING IN SILICO APPROACH

    Article • International Journal of Chemistry Research, May 2025, Innovare Academic Sciences Pvt Ltd

    Dr Seema Kumari

  5. Mesothelin as a Signal Pathways and Epigenetic Target in Cancer Therapy

    Article • Cancers, March 2025, MDPI AG

    Seema Kumari , Dr Seema Kumari

  6. Polysaccharides as therapeutic vehicles in pancreatic cancer

    Article • Drug Discovery Today, March 2025, Elsevier

    Seema Kumari , Dr Seema Kumari

  7. Challenges in immunotherapy for PDAC: Overcoming immune resistance and enhancing treatment strategies

    Article • January 2025, Elsevier

    Seema Kumari , Dr Seema Kumari

  8. Immunotherapy in colorectal cancer: Understanding the PD-1 and CTLA-4 targeted therapies for MSI-H/dMMR tumors

    Article • January 2025, Elsevier

    Seema Kumari , Dr Seema Kumari

  9. MMPs (-2 and -9)-mediated drug resistance and their reversal in gynecological cancer

    Article • January 2025, Elsevier

    Dr Seema Kumari

  10. Review Article: Understanding the Role of the Microbiome in Breast Cancer Progression

    Article • Critical Reviews™ in Oncogenesis, January 2025, Begell House

    Dr Seema Kumari

  11. Effect of Gut Dysbiosis on Onset of GI Cancers

    Article • Cancers, December 2024, MDPI AG

    Dr Seema Kumari

  12. Reactive oxygen species of tumor microenvironment: Harnessing for immunogenic cell death

    Article • Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, September 2024, Elsevier

    Dr Seema Kumari

  13. Quercetin and taxifolin inhibits TMPRSS2 activity and its interaction with EGFR in paclitaxel‐resistant breast cancer cells: An in silico and in vitro study

    Article • Chemical Biology & Drug Design, July 2024, Wiley

    Dr Seema Kumari

  14. Small molecular inhibitors: Therapeutic strategies for pancreatic cancer

    Article • Drug Discovery Today, July 2024, Elsevier

    Dr Seema Kumari

  15. Clinical implications and management strategies of resistance to anti-HER2 antibodies in breast cancer

    Article • January 2024, Elsevier

    Dr Seema Kumari

  16. A literature review on correlation between HPV coinfection with C. trachomatis and cervical neoplasia - coinfection mediated cellular transformation

    Article • Microbial Pathogenesis, July 2022, Elsevier

    Dr Seema Kumari

  17. Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer

    Article • Clinical Breast Cancer, April 2022, Elsevier

    Dr Seema Kumari

  18. Investigating the antioxidant and anticancer effect of alkaloids isolated from root extracts of Berberis aristata

    Article • Chemical Data Collections, February 2022, Elsevier

    Dr Seema Kumari

  19. Noncoding RNAs in HBV-associated hepatocellular carcinoma

    Article • January 2022, Elsevier

    Dr Seema Kumari

  20. Marine Cyclic Dipeptide Cyclo (L-Leu-L-Pro) Protects Normal Breast Epithelial Cells from tBHP-induced Oxidative Damage by Targeting CD151

    Article • Archives of Breast Cancer, July 2021, Archives of Breast Cancer

    Dr Seema Kumari

  21. Association of cervicovaginal dysbiosis mediated HPV infection with cervical intraepithelial neoplasia

    Article • Microbial Pathogenesis, March 2021, Elsevier

    Dr Seema Kumari

  22. Exosomes in Cancer Therapy-Literature Review

    Article • Journal of Clinical Oncology and Therapeutics, January 2021, Scholit Publishing LLC

    Dr Seema Kumari

  23. Current Trends in Therapeutics for Colon Cancer

    Article • Onco Therapeutics, January 2021, Begell House

    Dr Seema Kumari

  24. Nanotheranostics: Their role in hepatocellular carcinoma

    Article • Critical Reviews in Oncology/Hematology, July 2020, Elsevier

    Dr Seema Kumari

  25. Recent advances in metabolomics of triple negative breast cancer

    Article • The Breast Journal, March 2020, Wiley

    Dr Seema Kumari

  26. Marine natural compound cyclo(L-leucyl-L-prolyl) peptide inhibits migration of triple negative breast cancer cells by disrupting interaction of CD151 and EGFR signaling

    Article • Chemico-Biological Interactions, January 2020, Elsevier

    Dr Seema Kumari

  27. Mechanisms and Pathways of Metabolic Reprogramming of Colorectal Cancer

    Article • January 2020, Springer Science + Business Media

    Dr Seema Kumari

  28. Targeting Metabolic Reprogramming of Colorectal Cancer

    Article • January 2020, Springer Science + Business Media

    Dr Seema Kumari

  29. Cytotoxic Effect of Photoluminescent RE3+ Doped Ca3(PO4)2 Nanorods on Breast Cancer Cell Lines

    Article • IRBM, October 2019, Elsevier

    Dr Seema Kumari, Dr Vema Reddy Bheeram

  30. Effect of MMP-2 gene silencing on radiation-induced DNA damage in human normal dermal fibroblasts and breast cancer cells

    Article • Genes and Environment, July 2019, Springer Science + Business Media

    Dr Seema Kumari

  31. Horizons of nanotechnology applications in female specific cancers

    Article • Seminars in Cancer Biology, July 2019, Elsevier

    Dr Seema Kumari

  32. Synergistic enhancement of apoptosis by coralyne and paclitaxel in combination on MDA‐MB‐231 a triple‐negative breast cancer cell line

    Article • Journal of Cellular Biochemistry, June 2019, Wiley

    Dr Seema Kumari

  33. A perspective on the diagnostics, prognostics, and therapeutics of microRNAs of triple-negative breast cancer

    Article • Biophysical Reviews, February 2019, Springer Science + Business Media

    Dr Seema Kumari

  34. A comparative anticancer study on procyanidin C1 against receptor positive and receptor negative breast cancer

    Article • Natural Product Research, January 2019, Taylor & Francis

    Seema Kumari , Ramarao Malla, Dr Seema Kumari

  35. Cytogenetic, Molecular, and Translational Applications in Pancreatic Ductal Adenocarcinoma: Current Evidence and Future Concepts

    Article • Critical Reviews™ in Oncogenesis, January 2019, Begell House

    Dr Seema Kumari

  36. Drug resistance and microenvironment in pancreatic cancer

    Article • January 2019, Elsevier

    Dr Seema Kumari

  37. Terpenoids as Potential Targeted Therapeutics of Pancreatic Cancer: Current Advances and Future Directions

    Article • January 2019, Elsevier

    Dr Seema Kumari

  38. Synthesis, biological evaluation and molecular docking study of 1-amino-2-aroylnaphthalenes against prostate cancer

    Article • Bioorganic & Medicinal Chemistry Letters, May 2018, Elsevier

    Dr. Dharmendra Kumar Yadav, Dr Seema Kumari

  39. Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers

    Article • Asia-Pacific Journal of Clinical Oncology, March 2018, Wiley

    Dr Seema Kumari

  40. Reactive Oxygen Species: A Key Constituent in Cancer Survival

    Article • Biomarker Insights, January 2018, SAGE Publications

    Seema Kumari , Dr Seema Kumari

  41. CD151

    Article • January 2018, Springer Science + Business Media

    Dr Seema Kumari

  42. C-glycosyl flavone from Urginea indica inhibits proliferation & angiogenesis & induces apoptosis via cyclin-dependent kinase 6 in human breast, hepatic & colon cancer cell lines

    Article • International Journal of Microbiology Research, January 2018, Medknow

    Dr Seema Kumari

  43. Lipid rafts disruption induces apoptosis by attenuating expression of LRP6 and survivin in triple negative breast cancer

    Article • Biomedicine & Pharmacotherapy, January 2018, Elsevier

    Dr Seema Kumari

  44. Targeting Tumor Microenvironment and Metabolic Aberration Against TNBC

    Article • Insights in Biomedicine, January 2018, Scitechnol Biosoft Pvt. Ltd.

    Dr Seema Kumari

  45. C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice

    Article • Anti-Cancer Agents in Medicinal Chemistry, September 2017, Bentham Science Publishers

    Dr Seema Kumari

  46. Synergistic effects of coralyne and paclitaxel on cell migration and proliferation of breast cancer cells lines

    Article • Biomedicine & Pharmacotherapy, July 2017, Elsevier

    Dr Seema Kumari

  47. Knockdown of CD151 Gene Expression Reduces Survival of Estrogen Receptor Positive Breast Cancer Cells

    Article • Journal of Clinical & Experimental Oncology, January 2017, OMICS Publishing Group

    Dr Seema Kumari

  48. Coralyne Targets Proteases Involved in Cancer Progression: An In Silico Study

    Article • January 2016, Springer Science + Business Media

    Dr Seema Kumari

  49. Lipid Raft Integrity Is Required for Survival of Triple Negative Breast Cancer Cells

    Article • Journal of Breast Cancer, January 2016, Korean Breast Cancer Society (KAMJE)

    Dr Seema Kumari

  50. Studies on Optimization of Growth Parameters for Enhanced Production of Antibiotic Alkaloids by Isolated Marine actinomycetes

    Article • Journal of Applied Biology & Biotechnology, January 2016, Journal of Applied Pharmaceutical Science

    Dr Seema Kumari

  51. CD151

    Article • January 2016, Springer Science + Business Media

    Dr Seema Kumari

  52. Therapeutic Potentials of CD151 shRNA in Targeting Metastasis of Triple Negative Breast Cancer Cell Line MDA-MB-231

    Article • Journal of Cancer Science & Therapy, January 2016, OMICS Publishing Group

    Dr Seema Kumari

  53. CD151—A Striking Marker for Cancer Therapy

    Article • Biomarkers in Cancer, January 2015, SAGE Publications

    Dr Seema Kumari

  54. New Insight on the Role of Plasminogen Receptor in Cancer Progression

    Article • Cancer Growth and Metastasis, January 2015, SAGE Publications

    Dr Seema Kumari

  55. Anti-proliferative and metastatic protease inhibitory activities of protoberberines: An in silico and in vitro approaches

    Article • Process Biochemistry, October 2013, Elsevier

    Dr Seema Kumari